Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-07-30
1998-04-14
Jordan, Kimberly
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31355
Patent
active
057391564
ABSTRACT:
The subject invention involves a method of reducing non-ultraviolet-induced free radical damage in mammals comprising administering to a mammal a composition comprising a safe and effective amount of a compound selected from 2,4-dienoic acid esters of tocopherols and mixtures of such compounds.
REFERENCES:
patent: 3903297 (1975-09-01), Robert
patent: 3989816 (1976-11-01), Rhaadhyaksha
patent: 4017641 (1977-04-01), DiGiulio
patent: 4130667 (1978-12-01), Smith
patent: 4537776 (1985-08-01), Cooper
patent: 4552872 (1985-11-01), Cooper et al.
patent: 4557934 (1985-12-01), Cooper
patent: 4847071 (1989-07-01), Bissett et al.
patent: 4847072 (1989-07-01), Bissett et al.
patent: 4954487 (1990-09-01), Cooper et al.
Remington's Pharmasceutical Sciences, 17 ed., Chapter 85, p. 1518 (1985).
Buettner et al., :"Ascorbate Free Radical as a Marker of Oxidative Stress: An EPR Study", Free Radical Biology of Medicine, vol. 14 pp. 49-55 (1993).
Graff IV Milton B.
Henderson Loretta J.
Howell John M.
Jordan Kimberly
The Procter & Gamble & Company
LandOfFree
Methods of using 2,4-dienoic acid esters of tocopherols to reduc does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of using 2,4-dienoic acid esters of tocopherols to reduc, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of using 2,4-dienoic acid esters of tocopherols to reduc will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-635007